US Patent Issued to Pep2Tango Therapeutics on Sept. 15 for "Compositions including multi-agonist peptides and methods of manufacture and use" (Maryland, California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,457, issued on Sept. 15, was assigned to Pep2Tango Therapeutics Inc. (Potomac, Md.).

"Compositions including multi-agonist peptides and methods of manufacture and use" was invented by Cristina Martha Rondinone (Potomac, Md.), Soumitra S. Ghosh (San Diego) and Waleed Danho (Del Mar, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to novel multi-agonist peptides useful as agents for the treatment and prevention of metabolic diseases and disorders, for example those which can be alleviated by control of weight loss, plasma glucose and lipid levels, insulin levels, and/or insulin secretion, positive inotrop...